StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Volume

<< Previous

Bullboard Posts

Next >>

Comment by Northerencentson Apr 08, 2021 7:04pm

168 Views

Post# 32963972

RE:RE:RE:RE:RE:RE:Volume

To be totally clear, if our market cap had kept up with the increase in buisness it would be 25X yes 2500% even from our lows of say .04 .05 cents pre split that would be 1.25, post split 10 fkn dollars ...buisness wise that's all that needs priced in

but yes the market is always right and right now the market is unclear of a future with trip at the wheel, and I truly hope he realizes that....time to sh!t or get off the pot

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments